Electrospinning for Pharmaceutical Drug Delivery and Nanofiber Dosage Forms
Electrospinning for Pharmaceutical Drug Delivery and Nanofiber Dosage Forms
Electrospinning is increasingly investigated for pharmaceutical drug delivery, drug-loaded nanofibers, fast-dissolving oral and buccal films, localized therapy concepts, wound-dressing drug delivery and controlled-release nanofiber structures. This guide explains key formulation variables, dosage-form design routes, development risks and Inovenso options for proof of concept, prototype development, pilot validation or lab-scale equipment investment.
Technical overview: why electrospinning is used in pharmaceutical R&D
Electrospinning can transform polymer solutions containing active pharmaceutical ingredients into micro- or nanoscale fibrous matrices. These structures are valuable in pharmaceutical research because they combine high surface area, tunable porosity, flexible polymer selection and multiple drug loading strategies.
Pharmaceutical electrospinning is not limited to one dosage form. Depending on the polymer, solvent, active ingredient and collection method, electrospun nanofibers can be explored as fast-dissolving oral or buccal films, localized patches, wound-dressing drug delivery layers, controlled-release mats, implantable concepts, multilayer structures or coaxial core-shell fibers.
The key technical advantage is the ability to engineer the physical form of the drug-loaded matrix. A poorly water-soluble API may benefit from high surface area and amorphous dispersion strategies. A sensitive molecule may require mild processing and polymer protection. A sustained-release concept may require hydrophobic polymers, multilayer design or coaxial fiber architecture. Therefore, the formulation and process must be designed around the target release behavior and route of administration.
Typical engineering goal
The goal is to create a reproducible drug-loaded nanofiber structure that meets the intended performance target: fast disintegration, controlled release, localized delivery, mucoadhesion, mechanical handling, API stability or compatibility with downstream packaging and testing. The earlier these targets are defined, the easier it is to choose between proof-of-concept service, prototype sample development or in-house electrospinning equipment.
High surface area
Fine fibers can accelerate wetting and dissolution for selected fast-dissolving dosage-form concepts.
Tunable release
Polymer chemistry, fiber size, loading route and architecture can be adjusted for different release profiles.
Multiple architectures
Blend, emulsion, multilayer, side-by-side and coaxial electrospinning can support different R&D goals.
Prototype flexibility
Early-stage dosage-form concepts can be screened before selecting a pilot route or internal equipment.
Pharmaceutical application areas for electrospun nanofibers
Electrospinning can be adapted to different pharmaceutical research routes. Each route requires a different formulation strategy, test plan and equipment configuration.
Oral, buccal and sublingual nanofiber films
Hydrophilic polymer nanofibers can be investigated for rapid wetting and fast-disintegrating dosage-form prototypes.
- Fast-dissolving oral films
- Buccal and sublingual concepts
- Hydrophilic polymer screening
- Disintegration and handling balance
Sustained and modified-release nanofibers
Polymer selection and fiber architecture can be used to investigate delayed, biphasic or sustained release behavior.
- Hydrophobic polymer matrices
- Multilayer or blended systems
- Release profile development
- API-polymer compatibility
Drug-loaded patches and wound-dressing layers
Electrospun mats can be explored for local delivery where the drug-loaded layer remains close to the target site.
- Localized therapy concepts
- Wound dressing drug delivery
- Antimicrobial or analgesic loading
- Moisture and adhesion behavior
Key design parameters for pharmaceutical electrospinning projects
Pharmaceutical nanofiber development requires coordinated optimization of API stability, polymer matrix, drug loading, solvent system, morphology, release behavior and downstream handling.
Formulation and process variables
Pharmaceutical electrospinning is sensitive to both solution chemistry and environmental conditions. Small changes in formulation can alter fiber formation, dose loading, solid state and release behavior.
Nanofiber architecture options for pharmaceutical development
The required architecture depends on whether the target is rapid dissolution, controlled release, local delivery, sensitive API protection or multi-component formulation.
Drug-loaded blended nanofibers
API and polymer are processed in one solution. This route is often useful for early feasibility, fast screening and simple prototype development.
- Fast formulation screening
- Simple prototype preparation
- Useful for compatible API-polymer systems
Core-shell electrospun fibers
Coaxial electrospinning can separate API and shell material, support controlled release studies and reduce direct exposure of sensitive components.
- Core-shell release design
- Reduced burst-release studies
- Protection of selected active ingredients
Layered nanofiber structures
Sequential deposition can create multilayer mats for biphasic release, barrier layers, mechanical support or multi-API concepts.
- Immediate + sustained release concepts
- Barrier or support layers
- Multi-material dosage-form prototypes
Choose your pharmaceutical development path
Inovenso can support pharmaceutical nanofiber projects through proof of concept, feasibility studies, prototype sample development, pilot validation or in-house equipment configuration.
Proof of Concept & Feasibility
For teams that have an API, polymer or dosage-form concept but need to test whether electrospinning can create the desired morphology and release-oriented structure.
- API-polymer compatibility direction
- Polymer and solvent screening
- Fiber morphology development
- Initial dosage-form feasibility
Prototype Samples & Pilot Validation
For customers who need fast-dissolving film prototypes, drug-loaded nanofiber mats, localized delivery samples or validation batches before investing in their own electrospinning equipment.
- Prototype nanofiber dosage-form samples
- Core-shell or multilayer trials
- Small batch sample preparation
- Scale-up risk assessment
Equipment for In-House Pharmaceutical R&D
For laboratories and companies that want to develop pharmaceutical nanofiber dosage-form concepts, drug delivery systems or controlled-release structures internally.
- Lab-scale electrospinning systems
- Coaxial and bicomponent options
- Climate and camera modules
- Collector and substrate configuration
Recommended Inovenso route for pharmaceutical nanofiber projects
The right route depends on the development stage, API sensitivity, target release profile and whether you need service work, prototype samples or equipment for internal R&D.
| Customer situation | Recommended path | Typical Inovenso support |
|---|---|---|
| I have an API or dosage-form idea but no electrospinning formulation | PoC / Feasibility Service | Polymer screening, solvent selection, morphology development and initial prototype trials. |
| I need fast-dissolving nanofiber film prototypes | Prototype Sample Development | Hydrophilic polymer screening, mat formation, handling evaluation and sample preparation. |
| I need controlled-release or core-shell fibers | Coaxial / Multilayer Development | Core-shell feasibility, release-oriented architecture and process parameter development. |
| I want to perform pharmaceutical electrospinning inside my own lab | Lab-Scale Equipment | NanoSpinner24, NE300, NE200, NE100 or NanoSpinner Plus configuration. |
| I need wider validation or larger prototype batches | Pilot Equipment / Validation | PE-300, PE-550 or application-specific pilot configuration depending on process maturity. |
| I am not sure whether service or equipment is the right path | Application Consultation | Review of API, polymer/solvent, target release profile, regulatory stage and development roadmap. |
Recommended Inovenso systems and services for pharmaceutical electrospinning
Pharmaceutical projects can start with Inovenso R&D services, continue with prototype sample development and later move into in-house lab-scale or pilot-scale electrospinning equipment.
NanoSpinner24 and NE Series
For pharmaceutical R&D teams developing drug-loaded fibers, fast-dissolving films, controlled-release mats, coaxial nanofibers or controlled laboratory workflows.
NanoSpinner Plus, NS1 and Starter Systems
For early-stage academic or industrial teams that need to begin pharmaceutical electrospinning experiments with a compact and accessible configuration.
PE-300, PE-550 and Pilot Systems
For companies moving from lab coupon samples to larger prototype mats, validation batches or pre-production nanofiber dosage-form material development.
R&D, Prototype Samples and Application Development
For teams that want Inovenso to develop the formulation, produce proof-of-concept samples, validate nanofiber morphology or recommend a suitable equipment configuration.
Useful modules for pharmaceutical electrospinning workflows
Pharmaceutical applications often require specific fiber architectures, process control and documentation of repeatable experimental conditions. These modules can be considered during equipment configuration.
Coaxial / Bicomponent System
For core-shell fibers, controlled-release studies, sensitive API protection and multi-material nanofiber dosage-form concepts.
Climate Control and Temperature Control
For humidity-sensitive polymers, fast-dissolving formulations, repeatable solvent evaporation and morphology control.
Camera and Process Observation
For documenting jet stability, deposition quality, defect formation and experimental repeatability during formulation screening.
A practical pharmaceutical nanofiber development workflow
A pharmaceutical electrospinning project should move from API and polymer screening to prototype formulation, characterization, release testing and a clearly defined service or equipment route.
Define the target dosage form
Clarify whether the goal is fast-dissolving film, patch, controlled-release mat or core-shell fiber.
Select API and polymer route
Review API solubility, polymer compatibility, solvent strategy and target release behavior.
Develop morphology
Optimize fiber diameter, bead formation, dose loading, mat thickness and architecture.
Create prototype samples
Produce first nanofiber mats or films and evaluate handling, appearance and structure.
Plan characterization
Define API assay, content uniformity, residual solvent, release profile, stability and packaging needs.
Select the route
Continue with Inovenso R&D service, request pilot validation or configure in-house equipment.
Selected technical references
The following external publications provide useful background on electrospun nanofibers for drug delivery, fast-dissolving dosage forms and coaxial/core-shell controlled-release systems.
- Torres-Martínez E. J. et al., A Summary of Electrospun Nanofibers as Drug Delivery System, 2018.
- Ponrasu T. et al., Fast Dissolving Electrospun Nanofibers Fabricated from Jelly Fig Polysaccharide/Pullulan for Drug Delivery Applications, 2021.
- Pant B. et al., Drug Delivery Applications of Core-Sheath Nanofibers Prepared by Coaxial Electrospinning, 2019.
- Li J. et al., Drug Delivery Applications of Coaxial Electrospun Nanofibres in Cancer Therapy, 2022.
- Wildy M. et al., Electrospun Nanofibers: Shaping the Future of Controlled and Targeted Drug Delivery, 2023.
- Chou S. F. et al., Current strategies for sustaining drug release from electrospun nanofibers, 2015.
Request a pharmaceutical electrospinning consultation
Tell us whether you need proof of concept, prototype sample development, pilot validation or equipment recommendation for your pharmaceutical nanofiber application.
- Drug-loaded nanofiber proof-of-concept studies
- Fast-dissolving oral, buccal or sublingual film prototype development
- Controlled-release, coaxial or multilayer nanofiber feasibility
- Lab-scale electrospinning system recommendation
- Collector, climate control and process configuration support
Start your pharmaceutical nanofiber project
Please share your target dosage form, API/polymer information if available, solvent limitations, desired release profile, current development stage and whether you are interested in services, equipment or both.